Fresenius Medical Care to Offer Nephrology Electronic Health Record System for Chronic Kidney Disease.

WALTHAM, Mass. -- Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) (FWB:FME), the world's largest renal therapy company, today announced that is has entered into an agreement with Health IT Services Group (www.hitsg.com) to license its Web-based electronic health record for nephrologists in the United States to be marketed as Fresenius Medical Care CKD Solutions.

Fresenius Medical Care CKD Solutions offers broad interoperability with other health information systems and includes e-prescribing, as well as performance reporting. The electronic health record for nephrologists enables health care providers to capture and report data for pay-for-quality performance programs.

In addition, the electronic health record will populate a RenalNet CKD Consortium data registry providing an information tool for further research and understanding of chronic kidney disease.

Mats Wahlstrom, co-CEO of Fresenius Medical Care North America and President of Fresenius Medical Services, commented, "We are pleased to offer Fresenius Medical Care CKD Solutions to address the growing needs of nephrologists and their physician practice groups for a specialized electronic health record that captures relevant clinical data. This technology will enable nephrologists to monitor and further improve CKD patient outcomes."

More than 24 million Americans suffer from chronic kidney disease. According to Dr. Frank Maddux who, along with Dr. Dugan W. Maddux, developed Health IT Services Group, "The rising incidence and prevalence rates of diabetes and hypertension have led to an increase in the number of CKD patients. The ability of nephrologists to effectively care for these patients is dependent upon reliable and integrated clinical data. The electronic health record is a user-friendly product that efficiently captures clinical health care documentation, provides nephrology decision support and offers physician practice management tools."

Under the agreement, Health IT Services Group will provide training to physician practice groups using the software including ongoing support services.

Fresenius Medical Care is the world's largest integrated provider of products and services for individuals undergoing dialysis because of chronic kidney failure, a condition that affects about 1,500,000 individuals worldwide. Through its network of 2,108 dialysis clinics in North America, Europe, Latin America, Asia-Pacific and Africa, Fresenius Medical Care provides dialysis treatment to 163,517 patients around the globe. Fresenius Medical Care is also the world's leading provider of dialysis products such as hemodialysis machines, dialyzers and related disposable products. Fresenius Medical Care is listed on the Frankfurt Stock Exchange (FME, FME3) and the New York Stock Exchange (FMS, FMS-p).

For more information about Fresenius Medical Care visit the Company's website at www.fmc-ag.com.

This release contains forward-looking statements that are subject to various risks and uncertainties. Actual results could differ materially from those described in these forward-looking statements due to certain factors, including changes in business, economic and competitive conditions, regulatory reforms, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing. These and other risks and uncertainties are detailed in Fresenius Medical Care AG & Co. KGaA's reports filed with the U.S. Securities and Exchange Commission. Fresenius Medical Care AG & Co. KGaA does not undertake any responsibility to update the forward-looking statements in this release.